The Role of Type III Interferon in Innate Immunity to Respiratory Virus Infection
The Role of Type III Interferon in Innate Immunity to Respiratory Virus Infection
批准号:
7932906
负责人:
Joan E. Durbin
金额:
$80.99万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-17 至 2012-08-31
关键词:
Cell Culture TechniquesComplexDendritic CellsEpithelial CellsFamilyGene TargetingGenetic TranscriptionImmuneInfectionInfluenza A virusInterferon-alphaInterferonsMusNatural ImmunityProductionRelative (related person)Respiratory SystemRespiratory tract structureRoleSignal TransductionSourceTestingViralVirus Diseasescell typecytokineinfluenzavirusinterferon alpha receptorinterferon alpha-beta receptorinterferon-stimulated gene factor 3lambda phage receptormouse modelnovelpathogenreceptorrespiratory infection virus
中文摘要
描述(由申请人提供):III型干扰素(IFN)是一种新发现的细胞因子家族,与I型干扰素(α / β)一样,由病毒感染诱导。IFN-lambda的信号通过一种独特的受体,导致IFN- α / β激活的相同干扰素刺激基因因子3 (ISGF3)转录复合物的形成,因此具有非常相似的作用。到目前为止,I型和III型ifn之间的主要区别是IFN-lambda受体的分布非常有限,而ifn - α / β受体则普遍表达。由于ifn受体主要由上皮细胞和树突状细胞表达,因此有人认为该细胞因子可能在保护粘膜免受病毒病原体感染方面具有特别重要的作用。在甲型流感病毒感染的小鼠模型中,我们进行了新的观察,发现IFN-lambda是鼻内感染诱导的主要IFN,并且发现这种诱导即使在缺乏IFN- α / β信号传导的情况下也会发生。我们的假设是,这种可调节的抗病毒干扰素家族在保护宿主免受呼吸道病毒感染方面具有独特的作用。我们将使用基因靶向小鼠和原代气道上皮细胞培养来验证这一假设,以研究I型和III型ifn在呼吸道保护中重叠与独特功能的方式。我们提出以下目标:1)通过ISGF3证明IFN信号的必要性,并研究I型和III型IFN在有效的抗流感病毒先天免疫保护中的相对重要性。2)确定流感病毒感染中IFN-lambda的来源以及应答的细胞类型。3)表征极化气道上皮细胞对I型和III型ifn的产生和反应性。4)确定IFN-lambda在流感病毒感染时pDC成熟和功能中的作用。
英文摘要
DESCRIPTION (provided by applicant): Type III, or-lambda, interferons (IFN) make up a newly discovered family of cytokines which, like the type I IFNs (alpha/beta), are induced by virus infection. IFN-lambda's signaling, through a unique receptor, leads to formation of the same interferon stimulated gene factor 3 (ISGF3) transcription complex activated by IFN- alpah/beta, and therefore has very similar effects. The primary difference noted so far between the type I and type III IFNs is the very limited distribution of the IFN-lambda receptor, in contrast to the IFN-alpha/beta receptor which is ubiquitously expressed. As the IFN-lambda receptor is expressed primarily by epithelial cells and dendritic cells, it has been suggested that this cytokine may be of particular importance in protection from mucosal infections by viral pathogens. In a mouse model of influenza A virus infection we have made the novel observation that IFN-lambda is the primary IFN induced by intranasal infection, and have found that this induction can occur even in the absence of IFN-alpha/beta signaling. It is our hypothesis that this alternatively regulated family of anti-viral IFNs has a unique role in protecting the host from respiratory virus infection. We will test this hypothesis using gene-targeted mice and primary airway epithelial cell cultures to investigate the ways in which type I and type III IFNs have overlapping versus distinctive functions in protection of respiratory tract. We propose the following aims: 1) Demonstrate the requirement for IFN signaling via ISGF3, and investigate the relative importance of type I and type III IFNs for effective innate immune protection against influenza virus. 2) Identify the source(s) of IFN-lambda in influenza virus infection, as well the responding cell types. 3) Characterize production of, and responsiveness to, type I and type III IFNs by polarized airway epithelial cells. 4) Determine the role of IFN-lambda in pDC maturation and function during influenza virus infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUPPLEMENT TO: A Novel approach to RSV vaccination
-
批准号:8846767
-
项目类别:
-
资助金额:$52.55万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
-
批准号:8606404
-
项目类别:
-
资助金额:$118.56万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
-
批准号:8704177
-
项目类别:
-
资助金额:$103.69万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
-
批准号:8784187
-
项目类别:
-
资助金额:$118.59万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
-
批准号:8474421
-
项目类别:
-
资助金额:$15.02万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
-
批准号:9193608
-
项目类别:
-
资助金额:$119.03万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
A Novel Approach to RSV Vaccination
-
批准号:7905533
-
项目类别:
-
资助金额:$69.81万
-
财政年份:2010
-
负责人:Joan E. Durbin
-
依托单位:
SUPPLEMENT TO: A Novel approach to RSV vaccination
-
批准号:8811246
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2010
-
负责人:Joan E. Durbin
-
依托单位:
A Novel Approach to RSV Vaccination
-
批准号:8460820
-
项目类别:
-
资助金额:$20.48万
-
财政年份:2010
-
负责人:Joan E. Durbin
-
依托单位:
A Novel Approach to RSV Vaccination
-
批准号:8056668
-
项目类别:
-
资助金额:$60.01万
-
财政年份:2010
-
负责人:Joan E. Durbin
-
依托单位:
A Novel Approach to RSV Vaccination
-
批准号:8244370
-
项目类别:
-
资助金额:$60.15万
-
财政年份:2010
-
负责人:Joan E. Durbin
-
依托单位:
The Role of Type III Interferon in Innate Immunity to Respiratory Virus Infection
-
批准号:7996782
-
项目类别:
-
资助金额:$82.71万
-
财政年份:2009
-
负责人:Joan E. Durbin
-
依托单位:
Visualizing Interferon-beta Induction In Vivo
-
批准号:7532495
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2008
-
负责人:Joan E. Durbin
-
依托单位:
RSV Upper Airway Infection & Otitis Media
-
批准号:7000322
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2004
-
负责人:Joan E. Durbin
-
依托单位:
RSV Upper Airway Infection & Otitis Media
-
批准号:6848059
-
项目类别:
-
资助金额:$45.04万
-
财政年份:2004
-
负责人:Joan E. Durbin
-
依托单位:
RSV Upper Airway Infection & Otitis Media
-
批准号:6717512
-
项目类别:
-
资助金额:$43.73万
-
财政年份:2004
-
负责人:Joan E. Durbin
-
依托单位:
INTERFERON-ALPHA/BETA IN RESPIRATORY VIRUS PATHOGENESIS
-
批准号:6287381
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2001
-
负责人:Joan E. Durbin
-
依托单位:
INTERFERON-ALPHA/BETA IN RESPIRATORY VIRUS PATHOGENESIS
-
批准号:6511246
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2001
-
负责人:Joan E. Durbin
-
依托单位:
INTERFERON-ALPHA/BETA IN RESPIRATORY VIRUS PATHOGENESIS
-
批准号:6708082
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2001
-
负责人:Joan E. Durbin
-
依托单位:
INTERFERON-ALPHA/BETA IN RESPIRATORY VIRUS PATHOGENESIS
-
批准号:6556202
-
项目类别:
-
资助金额:$4.9万
-
财政年份:2001
-
负责人:Joan E. Durbin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TPLATE Complex通过胞吞调控CLV3-CLAVATA多肽信号模块维持干细胞稳态的分子机制研究
-
批准号:32370337
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:王杰
-
依托单位:
二甲双胍对于模型蛋白、γ-secretase、Complex I自由能曲面的影响
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郭子龙
-
依托单位:
高脂饮食损伤巨噬细胞ndufs4表达激活Complex I/mROS/HIF-1通路参与溃疡性结肠炎研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:赵锐
-
依托单位:
线粒体参与呼吸中枢pre-Bötzinger complex呼吸可塑性调控的机制研究
-
批准号:31971055
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:刘莹莹
-
依托单位:
北温带中华蹄盖蕨复合体Athyrium sinense complex的物种分化
-
批准号:31872651
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:张宪春
-
依托单位:
边缘鳞盖蕨复合体种 (Microlepia marginata complex) 的网状进化及物种形成研究
-
批准号:31860044
-
项目类别:地区科学基金项目
-
资助金额:37.0万元
-
批准年份:2018
-
负责人:王任翔
-
依托单位:
益气通络颗粒及主要单体通过调节cAMP/PKA/Complex I通路治疗气虚血瘀证脑梗死的机制研究
-
批准号:81703747
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:薛冰洁
-
依托单位:
生物钟转录抑制复合体 Evening Complex 调控茉莉酸诱导叶片衰老的分子机制研究
-
批准号:31670290
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:张媛媛
-
依托单位:
延伸子复合物(Elongator complex)的翻译调控作用
-
批准号:31360023
-
项目类别:地区科学基金项目
-
资助金额:51.0万元
-
批准年份:2013
-
负责人:黄波
-
依托单位:
Complex I 基因变异与寿命的关联及其作用机制的研究
-
批准号:81370445
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:杨泽
-
依托单位: